ArticleFrontiers in cell and developmental biology2026
Systematic analysis of programmed cell death-related genes in sepsis reveals immune heterogeneity and enables patient stratification.
Article in Frontiers in cell and developmental biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Crosstalk between innate immune signaling pathways and integrated TLR, NLRP3 inflammasome, cGAS-STING, and NF-κB networks in sepsis.Frontiers in cell and developmental biology · 2026Review
- Dendritic-cell depletion and dysfunction in sepsis: a compartment- and evidence-aware synthesis.Frontiers in immunology · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Sepsis is a life-threatening syndrome characterized by dysregulated host response to infection. Programmed cell death (PCD) pathways, including apoptosis, necroptosis, and pyroptosis, play a critical role in sepsis pathophysiology. However, the crosstalk between PCD, metabolic reprogramming, and immune heterogeneity remains poorly understood. Methods: We analyzed transcriptomic data from the GSE57065 and GSE95233 datasets. Differentially expressed genes (DEGs) were intersected with programmed cell death-related genes (PCDRGs). Consensus clustering was performed to identify molecular subtypes. A risk stratification model was constructed using LASSO and Random Forest algorithms. The immune landscape was deconvoluted using CIBERSORT. To validate cellular mechanisms, we integrated single-cell RNA sequencing (scRNA-seq) data, analyzing cell type-specific expression, intercellular communication (CellChat), and pathway enrichment. Additionally, the reliability of the identified signature was verified in a murine sepsis model (burn injury combined with Results: We identified 14 dysregulated PCDRGs in sepsis. Clustering based on these genes revealed two distinct patient subgroups: an "adaptive-dominant" cluster (enriched in T cell activation) and an "innate-dominant" cluster (enriched in neutrophil degranulation and heme metabolism). A 5-gene risk signature (IFNGR1, PYGL, JAK2, HMGB2, BMX) was constructed, which robustly stratified patients in the discovery and external validation cohorts (AUC > 0.97). Experimental validation in septic mice confirmed that the expression levels of all five hub genes were significantly upregulated in peripheral blood, consistent with the human transcriptomic findings. High-risk patients exhibited severe immune imbalance characterized by neutrophil/monocyte expansion and lymphocyte depletion. Single-cell analysis confirmed that hub genes were predominantly expressed in myeloid lineages. Furthermore, high-risk patients displayed intensified Monocyte-Dendritic Cell (DC) crosstalk driven by inflammatory signaling, with transcriptional programs in these cells converging on neutrophil degranulation pathways. Conclusion: This study establishes a robust PCDRG-based risk signature that captures the immune-metabolic heterogeneity of sepsis. The signature enables patient stratification and reflects disease-associated immune states. Our findings suggest a potential association between dysregulated PCD genes in myeloid cells and an innate immune-dominant, hyper-inflammatory phenotype, providing potential biomarkers and therapeutic insights for sepsis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.